Pharmacology

Action Mechanism of Action Reference
AGONIST Luteinizing hormone/Choriogonadotropin receptor agonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hypogonadism 3 D007006 ClinicalTrials
Polycystic Ovary Syndrome 3 D011085 ClinicalTrials
Pregnancy 3 D011247 ClinicalTrials
Hypogonadism 3 D007006 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Infertility 3 D007246 ClinicalTrials
Azoospermia 2 D053713 ClinicalTrials
Anovulation 2 D000858 ClinicalTrials
Gonadal Disorders 1 D006058 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
15.13
Injury, poisoning and procedural complications
14.49
Reproductive system and breast disorders
11.31
Endocrine disorders
10.09
Vascular disorders
5.62
Pregnancy, puerperium and perinatal conditions
5.29
Nervous system disorders
4.68
Gastrointestinal disorders
4.34
Product issues
3.42
Respiratory, thoracic and mediastinal disorders
3.39
Cardiac disorders
3.0
Skin and subcutaneous tissue disorders
2.87
Investigations
2.69

Cross References

Resources Reference
ChEMBL CHEMBL1201509
FDA SRS 20ED16GHEB